Archives

by in
Entry Author Date Location
Biogen Idec, Vertex, and Genzyme Try Different Ways to Skin the Innovation Cat 12/19/07 Boston
Biogen Inks $380 Million Deal With Swiss Company 11/20/07 Boston
Bidding for Biogen Idec Could Begin in Early November, Report Says 10/26/07 Boston
Biogen-Icahn? Pfiz-ogen or Pfiz-zyme? Is All of Cambridge Biotech Suddenly Up For Sale? 10/24/07 Boston
Icahn Offered $23 Billion for Biogen Idec—Elan Won’t Block Sale 10/15/07 Boston
Biogen Idec on the Block; Icahn’s Interest in Buying the Firm Confirmed 10/12/07 Boston
Carl Icahn: Biogen Idec Marriage Broker? 08/27/07 Boston
Icahn Gets Okay to Purchase Biogen Idec Shares 08/25/07 Boston
Color Kinetics Sale on Track, Boston Scientific and Amgen Retrench, & More 08/17/07 Boston
Keeping Biogen Idec Innovative: Jim Mullen Interview (Part 2) 08/17/07 Boston
Icahn’s New Stake in Biogen Idec—Doing the Math 08/16/07 Boston
The State of Biotechnology, According to Biogen Idec CEO Jim Mullen 08/16/07 Boston
Cleaning the Slate, Raising Funds, and Filling the Executive Suite 08/13/07 Boston
FDA Panel Votes in Favor of Biogen’s Tysabri for Crohn’s Disease 08/01/07 Boston
Can Biogen’s New Incubator Help Fill the Drug Pipeline? 07/19/07 Boston
Page 2 of 2 « previous page
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.